[go: up one dir, main page]

BR0007718A - Utilização de derivados depiridazino[4,5-b]indol-1-acetamida para preparaçãode medicamentos para doenças ligadas à disfunçãode receptores de benzodiazepina do tipoperiférico - Google Patents

Utilização de derivados depiridazino[4,5-b]indol-1-acetamida para preparaçãode medicamentos para doenças ligadas à disfunçãode receptores de benzodiazepina do tipoperiférico

Info

Publication number
BR0007718A
BR0007718A BR0007718-6A BR0007718A BR0007718A BR 0007718 A BR0007718 A BR 0007718A BR 0007718 A BR0007718 A BR 0007718A BR 0007718 A BR0007718 A BR 0007718A
Authority
BR
Brazil
Prior art keywords
depiridazine
acetamide
derivatives
preparation
peripheral type
Prior art date
Application number
BR0007718-6A
Other languages
English (en)
Inventor
Badia Ferzaz
Jesus Benavides
Frank Marguet
Jacques Froissant
Benoit Marabout
Yannick Evanno
Mireille Sevrin
Philip Janiak
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR0007718A publication Critical patent/BR0007718A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: "UTILIZAçãO DE DERIVADOS DEPIRIDAZINO [4,5-b]INDOL-1-ACETAMIDA PARA PREPARAçãODE MEDICAMENTOS PARA DOENçAS LIGADAS à DISFUNçãODE RECEPTORES DE BENZODIAZEPINA DO TIPOPERIFéRICO". A invenção refere-se ao uso de um composto dafórmula geral (1) onde: X representa um átomo de halogênio, Yrepresenta um ou vários átomos ou grupos selecionados dentrehidrogênio, halogênios e hidroxila, grupos metila, metóxi e nitro; R~1~ representa um grupo (C~ 1~-C~ 4~) alquila, R~ 3~ e R~ 3~cada um representa, independentemente do outro, um átomo dehidrogênio ou um grupo (C~ 1~-C~ 4~) alquila ou R~ 2~ e R~ 3~em conjunto formam com o átomo de nitrogênio portando osmesmos, um grupo pirrolidinila, piperidinila ou morfolinila para apreparação de um medicamento para prevenção e tratamento dedoenças e distúrbios relacionados à disfunção dos receptores debenzodiazepina do tipo periférico.
BR0007718-6A 1999-01-26 2000-01-21 Utilização de derivados depiridazino[4,5-b]indol-1-acetamida para preparaçãode medicamentos para doenças ligadas à disfunçãode receptores de benzodiazepina do tipoperiférico BR0007718A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900806A FR2788696B1 (fr) 1999-01-26 1999-01-26 Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
PCT/FR2000/000135 WO2000044384A1 (fr) 1999-01-26 2000-01-21 UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AUX MALADIES LIEES AU DYSFONCTIONNEMENT DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES

Publications (1)

Publication Number Publication Date
BR0007718A true BR0007718A (pt) 2001-11-13

Family

ID=9541212

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007718-6A BR0007718A (pt) 1999-01-26 2000-01-21 Utilização de derivados depiridazino[4,5-b]indol-1-acetamida para preparaçãode medicamentos para doenças ligadas à disfunçãode receptores de benzodiazepina do tipoperiférico

Country Status (32)

Country Link
US (1) US6395729B1 (pt)
EP (1) EP1148881B1 (pt)
JP (1) JP4688295B2 (pt)
KR (1) KR100694752B1 (pt)
CN (1) CN100577167C (pt)
AR (1) AR022413A1 (pt)
AT (1) ATE335487T1 (pt)
AU (1) AU764445B2 (pt)
BG (1) BG65152B1 (pt)
BR (1) BR0007718A (pt)
CA (1) CA2360754C (pt)
CO (1) CO5160242A1 (pt)
CY (1) CY1106257T1 (pt)
CZ (1) CZ294283B6 (pt)
DE (1) DE60029929T2 (pt)
DK (1) DK1148881T3 (pt)
EE (1) EE04905B1 (pt)
ES (1) ES2269097T3 (pt)
FR (1) FR2788696B1 (pt)
HK (1) HK1040905B (pt)
HU (1) HU228670B1 (pt)
IL (2) IL144181A0 (pt)
NO (1) NO321997B1 (pt)
NZ (1) NZ512981A (pt)
PL (1) PL193420B1 (pt)
PT (1) PT1148881E (pt)
RU (1) RU2243764C2 (pt)
SK (1) SK285707B6 (pt)
TR (1) TR200102134T2 (pt)
TW (1) TW541177B (pt)
UA (1) UA70349C2 (pt)
WO (1) WO2000044384A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201215A2 (en) * 1998-12-02 2002-08-28 Pfizer Prod Inc Methods and compositions for restoring conformational stability of a protein of the p53 family
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
FR2876715B1 (fr) 2004-10-19 2006-12-15 Profiles Du Ct Sa Embout de protection pour ecran de glissiere de securite routiere
GT200600005A (es) * 2005-01-12 2006-08-16 Un derivado de 2-(aminocarbonilo ciclico)-indolina y una composicion farmaceutica que lo contiene
NZ562559A (en) * 2005-05-05 2011-03-31 Sanofi Aventis Us Llc Stable nanoparticle formulations smaller than 1000 nm without the use of any surface modifier or stabilizzer absorbed onto the surface of the particles
EA015715B1 (ru) * 2005-08-29 2011-10-31 САНОФИ-АВЕНТИС Ю. Эс. ЭлЭлСи Твердая дисперсия, фармацевтическая композиция, включающая такую дисперсию, способ ее получения и применение для предотвращения и лечения заболеваний, связанных с бензодиазепиновыми рецепторами периферического типа
CN101253176B (zh) * 2005-08-29 2012-04-18 赛诺菲-安万特美国有限责任公司 哒嗪并[4，5-b]吲哚衍生物的新晶形
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
JP2012500268A (ja) * 2008-08-18 2012-01-05 サノフィ−アベンティス・ユー・エス・エルエルシー ７−クロロ−Ｎ，Ｎ，５−トリメチル−４−オキソ−３−フェニル−３，５−ジヒドロ−４Ｈ−ピリダジノ［４，５−ｂ］インドール−１−アセトアミドの多形体を製造するための方法
GB0818738D0 (en) * 2008-10-13 2008-11-19 Ge Healthcare Ltd Imaging neuroflammation
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
EP2181717A1 (en) 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels
WO2011073576A2 (fr) 2009-12-18 2011-06-23 L'oreal Procede de coloration de la peau impliquant un compose apte a condenser in situ et un agent colorant de la peau
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121137A1 (de) * 1981-05-27 1982-12-16 Hoechst Ag, 6000 Frankfurt Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung"
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6069267A (en) * 1997-07-29 2000-05-30 E. I. Du Pont De Nemours And Company Selective synthesis of organodiphosphite compounds
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
HK1040905A1 (en) 2002-06-28
TW541177B (en) 2003-07-11
HU228670B1 (en) 2013-05-28
IL144181A0 (en) 2002-05-23
NO20013645D0 (no) 2001-07-24
HUP0201280A2 (en) 2002-08-28
CN100577167C (zh) 2010-01-06
PT1148881E (pt) 2006-12-29
SK10502001A3 (sk) 2002-01-07
HUP0201280A3 (en) 2004-12-28
PL349364A1 (en) 2002-07-15
CZ294283B6 (cs) 2004-11-10
KR20010089624A (ko) 2001-10-06
AU3057900A (en) 2000-08-18
ES2269097T3 (es) 2007-04-01
CO5160242A1 (es) 2002-05-30
DK1148881T3 (da) 2006-12-11
EP1148881B1 (fr) 2006-08-09
IL144181A (en) 2007-06-17
CY1106257T1 (el) 2011-06-08
JP4688295B2 (ja) 2011-05-25
FR2788696A1 (fr) 2000-07-28
CN1344161A (zh) 2002-04-10
DE60029929T2 (de) 2007-08-30
BG105728A (en) 2002-02-28
NZ512981A (en) 2002-10-25
SK285707B6 (sk) 2007-06-07
UA70349C2 (en) 2004-10-15
KR100694752B1 (ko) 2007-03-14
ATE335487T1 (de) 2006-09-15
CA2360754A1 (en) 2000-08-03
AU764445B2 (en) 2003-08-21
CA2360754C (en) 2008-07-08
RU2243764C2 (ru) 2005-01-10
FR2788696B1 (fr) 2004-03-05
BG65152B1 (bg) 2007-04-30
JP2002535370A (ja) 2002-10-22
PL193420B1 (pl) 2007-02-28
DE60029929D1 (de) 2006-09-21
EE04905B1 (et) 2007-10-15
WO2000044384A1 (fr) 2000-08-03
CZ20012681A3 (cs) 2001-10-17
NO20013645L (no) 2001-09-26
AR022413A1 (es) 2002-09-04
HK1040905B (zh) 2007-02-23
EE200100388A (et) 2002-12-16
US6395729B1 (en) 2002-05-28
EP1148881A1 (fr) 2001-10-31
NO321997B1 (no) 2006-07-31
TR200102134T2 (tr) 2003-03-21

Similar Documents

Publication Publication Date Title
BR0007718A (pt) Utilização de derivados depiridazino[4,5-b]indol-1-acetamida para preparaçãode medicamentos para doenças ligadas à disfunçãode receptores de benzodiazepina do tipoperiférico
BRPI9608082B8 (pt) derivado de quinazolina, sal de cloridreto do mesmo, e, composição farmacêutica
AR029454A1 (es) Derivados de piperazina sustituidos, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la elaboracion de medicamentos
BR0208678A (pt) Composto, composição farmacêutica, uso de um composto
BR0215312A (pt) Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto
HUP0004412A2 (hu) Heterociklikus vinil-éterek alkalmazása neurológiai rendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására
CO5180642A1 (es) Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion
MA29213B1 (fr) Quinolones a substitution macrolones - amino
BR0211305A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto
TR200100694T2 (tr) Opioid alıcı aktivitesine sahip 4,4-Biarilpiperidin türevleri
DE60018274D1 (de) Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden
BR9713147A (pt) Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal.
BR9807339A (pt) Derivados 3-piperidil-4-oxoquinazolina e composições farmacêuticas compreendendo os mesmos.
ATE307127T1 (de) 2,4-substituierte pyridinderivate
DE60001586D1 (de) Diphenyl-piperidin derivate
BRPI0508243A (pt) derivados de anéis fundidos nitrogenados, composições medicinais contendo os derivados e uso destas como drogas
ATE236147T1 (de) Derivate von flavonen, xanthonen und kumarinen
BR0215650A (pt) Preparação combinada para a administração simultânea, separada, ou sequencial no tratamento do câncer, método para o tratamento do câncer, uso de pelo menos um composto, e, composição farmacêutica
BRPI0508107A (pt) derivados de indazol e composições farmacêuticas contendo os mesmos
BR0308338A (pt) Derivados de nitrosodifenilamina e seu uso farmacêutico contra patologias de estresse oxidativo
BR0314182A (pt) Formulações compreendendo um composto de indolinona
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
BR0015821A (pt) Derivados de pirimidina
RU2001121160A (ru) Применение производных пиридазино[4,5-b]индол-1-ацетамида для приготовления лекарств для лечения заболеваний, связанных с дисфункцией бензодиазепиновых рецепторов периферического типа
BR9810337A (pt) Utilização de um antagonista especìfico dos receptores 5ht2 para a preparação de medicamentos úteis no tratamento da sìndrome de apnéia do sono

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 24 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]